Steve Blank Archives - Mediformatica

Artera Launches with $90M for Multimodal AI, Predictive Cancer Tests

March 21, 2023April 11, 2023HIT Consultant

What You Should Know:– Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly today with $90M in funding.– The investment comes from a syndicate of prominent tech and healthcare…

Artera launches with $90M to personalize prostate cancer therapy

March 14, 2023April 11, 2023MobiHealthNews

Calif.-based Artera, which offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients, announces its launch alongside a $90 million investment.Johnson & Johnson, TIME Ventures, Koch Disruptive Technologies, Coatue, Walden Catalyst Ventures,…

We noticed you've been enjoying MediFormatica's content. Would you like to get notifications on the latest Health Tech news? OK No thanks

How 3 Health Systems Are Scaling Hybrid & Home-Based Models – MedCity News

Korean AI predicts mood episodes using sleep-wake data

News 11/27/24 – HIStalk

Google releases open foundation models for health app developers

Tag: Steve Blank

Artera Launches with $90M for Multimodal AI, Predictive Cancer Tests

Artera launches with $90M to personalize prostate cancer therapy

How 3 Health Systems Are Scaling Hybrid & Home-Based Models – MedCity News

Korean AI predicts mood episodes using sleep-wake data

News 11/27/24 – HIStalk

Google releases open foundation models for health app developers

MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding – MedCity News

Health2Tech event in Boston #digitalhealth

New NIH tool uses genAI to connect volunteers with clinical trials

An Evaluation of the Effect of App-Based Exercise Prescription Using Reinforcement Learning on Satisfaction and Exercise Intensity: Randomized Crossover Trial

GE HealthCare unveils new mammography system

Q&A: Dexcom on forming partnerships and its CGM technology

MediFormatica

News Aggregator